Abstract:Background Emerging evidence has proven that long noncoding RNAs (lncRNAs) play important roles in human colorectal cancer (CRC) biology, while few lncRNAs have been characterised in CRC. Therefore, the functional significance of lncRNAs in the malignant progression of CRC still needs to be further explored. Methods By utilising publicly available lncRNAs expression profiling data and other publicly available lncRNAs expression profiling data, we screened out LINC00460, whose expression is significantly increased in CRC. The quantitative reverse transcriptase PCR (qRT-PCR) was used to analyse the expression of LINC00460 in 60 CRC tissues and correspond adjacent normal tissues and four CRC cell lines. Gain and loss of function approaches were used to investigate the biological role of LINC00460 both in vitro and in vivo. Bioinformatics analysis followed by qRT-PCR was performed to identify the putative targets of LINC00460, which were further verified by RNA immunoprecipitation (RIP), Chromatin immunoprecipitation (ChIP), Luciferase reporter assays, rescue experiments and western blotting assays. Results We found a novel lncRNA, LINC00460, whose expression was significantly over-expressed in all three publicly available microarray data. Consistently, qRT-PCR results also verified that LINC00460 was over-expressed in CRC tissues and cells. Furthermore, high LINC00460 expression levels in CRC specimens were correlated with larger tumour size, advanced tumour stage, lymph node metastasis and shorter overall survival. In vitro and in vivo assays of LINC00460 alterations revealed a complexly integrated phenotype affecting cell growth and apoptosis. Mechanistically, LINC00460 repressed kruppel like factor 2 (KLF2) transcription by binding to the enhancer of zeste homolog 2 (EZH2). LINC00460 also functioned as a molecular sponge for miR-149–5 p, antagonising its ability to repress cullin 4A (CUL4A) protein translation. Conclusions Taken together, our findings support a model in which the LINC00460/EZH2/KLF2 and LINC00460/miR-149–5 p/CUL4A crosstalk serve as critical effectors in CRC tumorigenesis and progression, suggesting new therapeutic directions in colorectal cancer.

DCAF4L2 Promotes Colorectal Cancer Invasion and Metastasis Via Mediating Degradation of NFκb Negative Regulator PPM1B.

Lnc-FAM84B-4 acts as an oncogenic lncRNA by interacting with protein hnRNPK to restrain MAPK phosphatases-DUSP1 expression.

MFAP2, Upregulated by M1a Methylation, Promotes Colorectal Cancer Invasiveness Via CLK3.

BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancer

IDDF2018-ABS-0125 Overexpression of LNCRNA LINC00460 Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer

AFF4 Predicts the Prognosis of Colorectal Cancer Patients and Suppresses Colorectal Cancer Metastasis via Promoting CDH1 Expression

DTL Promotes Cancer Progression by PDCD4 Ubiquitin-Dependent Degradation

ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2

Pdcd4 Deficiency Aggravated Colitis And Colitis-Associated Colorectal Cancer Via Promoting Il-6/Stat3 Pathway In Mice

Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2

Down-Regulation of Dab2ip Promotes Colorectal Cancer Invasion and Metastasis by Translocating Hnrnpk into Nucleus to Enhance the Transcription of Mmp2

A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation

Overexpression of Mrna-Decapping Enzyme 1a Affects Survival Rate in Colorectal Carcinoma.

CRL4DCAF1/VprBP E3 Ubiquitin Ligase Controls Ribosome Biogenesis, Cell Proliferation, and Development.

Wnt Signaling Modulator DKK4 Inhibits Colorectal Cancer Metastasis Through an AKT/Wnt/β-catenin Negative Feedback Pathway.

DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression

Long Noncoding RNA LINC01594 Inhibits the CELF6-mediated Splicing of Oncogenic CD44 Variants to Promote Colorectal Cancer Metastasis

DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma

Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour metastasis

DEAD-box Helicase 27 Promotes Colorectal Cancer Growth and Metastasis and Predicts Poor Survival in CRC Patients

A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML)